Exelixis (NASDAQ: EXEL) reported Q4 EPS of $0.26, $0.10 better than the analyst estimate of $0.16. Revenue for the quarter came in at $240.3 million versus the consensus estimate of $240.52 million.

GUIDANCE:

Exelixis sees FY2020 revenue of $850-900 million, versus the consensus of $944 million.

Total revenues		$850 million - $900 million
Net product revenues		$725 million - $775 million
Cost of goods sold		4% - 5% of net product revenues
Research and development expenses(1)		$460 million - $500 million
Selling, general and administrative expenses(2)		$230 million - $250 million
Effective tax rate		20% - 22%
Cash and investments(3)		$1.5 billion - $1.6 billion

For earnings history and earnings-related data on Exelixis (EXEL) click here.